APPLIED CLINICAL TRIALS Issue Alert Having trouble viewing this email? Click here
Web Version | View Digital Edition | Subscribe
In our March issue:

FEATURED
Clinical Research Talent Trends
 With findings from a new ACT and SCORR Marketing talent survey, the latest hiring and retention practices in the life sciences are explored. The impact of millennials on clinical research and safeguarding trials from CRO turnover are also looked at in this section.

PEER-REVIEWED ARTICLES

 Safety Boost from FSPs
Chitra Lele, PhD
Meeting today's complex regulatory demands when it comes to drug safety and pharmacovigilance can be especially challenging for small and medium-sized organizations. This report presents the benefits for these companies in outsourcing such activities to functional service providers (FSPs) during clinical trials and post-approval.
Cancer Trials: Liquid Biopsy Surge
Joy Yucaitis
The ability to diagnose cancer at earlier stages of the disease is constrained by the specificity and mechanics of traditional diagnostic methods. The growing use of liquid biopsy technology may help overcome such barriers and potentially revolutionize cancer research, patient treatment, and survivor care.
NEWS
Washington Report: Jill Wechsler details the two chief reasons why clinical trial quality and efficiency have improved in recent years.

EU Report: Peter O’Donnell weighs the varying views in Europe on the risks of going the adaptive pathways route for drug approval.

Rare Disease: Rare disease interests in Europe add more voices to push for greater backing of research incentives, infrastructure.

CLINICAL TRIAL INSIGHTS
Managing Data Overload
Ken Getz
Amid industry feedback that the growing volume and diversity of eClinical data collected for studies is taxing cycle times, two studies highlight the need to optimize protocol design and executional complexity to overcome these data management burdens.
CLOSING THOUGHT

The Search for Patient X
Lori Goldberg
Digital media is becoming a crucial vehicle for finding “Patient X” for rare disease drug trials. Three areas in particular where digital media is helping with the detective work are explored.

Download the
issue:
image
 
BLOGS
An Encouraging Snapshot of New Drug Approvals in 2017
FDA Cracks Down on Incomplete Applications
Applying Learning Health Systems to Advance Clinical Research and Healthcare
WEBCAST
The Benefits of a Data-Driven Approach to Feasibility
Learn how data-driven feasibility is at the heart of today's industry challenges, by connecting the most relevant patient, site, and investigator data with analytic tools and targeted processes during study startup.

If you would like to submit an article to Applied Clinical Trials, contact Lisa Henderson, Editorial Director - [email protected]

Applied Clinical Trials is free to qualified subscribers. To subscribe, click here.

Click here to contact the Applied Clinical Trials sales team.
Twitter LinkedIn